Concerning the debate about homocysteine, B vitamins, and dementia

It is important to identify modifiable risk factors for dementia and to introduce policies to implement their modification. The Lancet Commission on Dementia Prevention, Intervention and Care failed to identify raised plasma homocysteine as a risk factor, despite considerable evidence; hence there i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Alzheimer's disease Jg. 106; H. 3; S. 920
Hauptverfasser: Miller, Joshua W, McCaddon, Andrew, Yu, Jin-Tai, Hooshmand, Babak, Refsum, Helga, Smith, A David
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.08.2025
Schlagworte:
ISSN:1875-8908, 1875-8908
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:It is important to identify modifiable risk factors for dementia and to introduce policies to implement their modification. The Lancet Commission on Dementia Prevention, Intervention and Care failed to identify raised plasma homocysteine as a risk factor, despite considerable evidence; hence there is a need for a debate on this matter.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1875-8908
1875-8908
DOI:10.1177/13872877251350297